Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Indonesian Drug Makers Squeezed By Raw Material, Fuel Costs

This article was originally published in PharmAsia News

Executive Summary

The Indonesian Pharmaceutical Association said the country's drug making industry has begun to suffer the high price of raw materials imported from China. The prices of some branded drugs in Indonesia already have doubled as a result of having to pass on the higher production costs due to as much as 95 percent increases in some materials. The head of the association said that in general the Indonesia prices of branded drugs have increase by between 5 percent and 10 percent," below the increase manufacturers would make if their consumers were not already facing their financial squeeze due to the cost of fuel. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts